More Cambium Bio Ltd news
Cambium Bio LtdASX: CMB

Regeneus to be granted new Sygenus patent in Canada

Oct 6, 2020 at 11:20 PM EDT · Issued by Cambium Bio Ltd

Filed with ASX · Oct 6, 2020 at 11:20 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/regeneus-to-be-granted-new-sygenus-patent-in-canada

Cambium Bio Ltd on 6ix

Story so far

  • US Patent for SygenusAug 19, 2020

Earlier from Cambium Bio

  • Regeneus receives milestone payment from KyoceraAug 28, 2020
  • Appendix 4E and Annual ReportAug 28, 2020
  • Regeneus to present at FNN Virtual Investor EventAug 25, 2020
  • US Patent for SygenusAug 18, 2020
  • Regeneus and Kyocera sign Progenza OA dealAug 11, 2020

Later from Cambium Bio

  • Regeneus receives $5.6M milestone payment from KyoceraOct 29, 2020
  • CEO Appointment and ResignationNov 1, 2020
  • Clarification on Quarterly Activity Report and Appendix 4CNov 10, 2020
  • Appendix 4C - Quarterly ReportJan 28, 2021
  • Response to ASX Appendix 4C QueryFeb 4, 2021
All Cambium Bio news releases↗

Follow Cambium Bio into a list and get an email when it puts out news.

Follow Cambium Bio
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer